Los Angeles, New York, Stanford University: HBY 097, new drug may weaken HIV.

Abstract excerpt

A three-month human trial will be conducted in Los Angeles, New York, and San Francisco, to test a new drug, HBY 097. In laboratory tests, HBY 097 has weakened HIV. Volunteers will begin a regimen of either HBY 097, AZT, or the combination. The study will measure all mutations that develop in the HIV reverse transcriptase enzyme. Participants must have a CD4 count between 200 and 500, and have not received any...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acquired Immunodeficiency Syndrome
• Share to HIV
• Share to Los Angeles